SBRT Added to Standard Tx Boosts Outcomes in Oligometastatic PCa - ARTO II~ Improved response & PFS compared to SOC, MedPage Today, 09/27/23
[/i]
[i]In a cohort of 157 patients at 6 months after the start of treatment, biochemical response was detected in 92% of those who received SBRT with abiraterone acetate (Zytiga) and prednisone versus 68.3% of those treated with standard systemic therapy alone (OR 5.34, 95% CI 2.05-13.88, P=0.001),
[/i]
[i]In a cohort of 157 patients at 6 months after the start of treatment, biochemical response was detected in 92% of those who received SBRT with abiraterone acetate (Zytiga) and prednisone versus 68.3% of those treated with standard systemic therapy alone (OR 5.34, 95% CI 2.05-13.88, P=0.001),